Cart is empty Melbourne researchers have designed a single drug that delivers a lethal “one-two” punch to several types of blood cancer in preclinical studies and could lead to improved treatments.
Melbourne researchers have designed a single drug that delivers a lethal “one-two” punch to several types of blood cancer in preclinical studies and could lead to improved treatments.
Leave A Comment